GLUT1-DS is a mutational based genetic disorder resulting in the aberrant expression of the transporter GLUT1, thus affecting its ability to intake glucose (Klepper et al., 2020) and leading to cognitive impairment, and drug resistant seizures. The gene discussed is SLC2A1; the disease is Dravet syndrome.